GI Insider Trading Activity and SEC Form 4 Filings
GI insider trading summary
No open-market insider purchases or sales of EndoChoice Holdings, Inc. (GI) have been reported on SEC Form 4 in the past 12 months.
Latest GI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 16, 2016 | Mark Gilreath | Chief Executive Officer | Buy | $101K (20,000 @ $5.06) |
| Mar 15, 2016 | Mark Gilreath | Chief Executive Officer | Buy | $10K (1,818 @ $5.50) |
| Mar 11, 2016 | J Scott Carter | Director | Buy | $93K (19,280 @ $4.82) |
| Mar 11, 2016 | David L Kaufman | Director | Buy | $430K (89,450 @ $4.81) |
| Mar 11, 2016 | Mark Gilreath | Chief Executive Officer | Buy | $15K (3,200 @ $4.75) |
| Mar 10, 2016 | David N Gill | Chief Financial Officer | Buy | $9K (2,000 @ $4.70) |
| Mar 10, 2016 | William R Enquist | Director | Buy | $47K (10,000 @ $4.74) |
| Mar 10, 2016 | David L Kaufman | Director | Buy | $392K (83,700 @ $4.68) |
| Mar 10, 2016 | J Scott Carter | Director | Buy | $101K (21,620 @ $4.68) |
| Mar 9, 2016 | J Scott Carter | Director | Buy | $131K (28,375 @ $4.63) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.